BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 15066758)

  • 1. Polymeric anticancer drugs with pH-controlled activation.
    Ulbrich K; Subr V
    Adv Drug Deliv Rev; 2004 Apr; 56(7):1023-50. PubMed ID: 15066758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.
    Bae Y; Nishiyama N; Fukushima S; Koyama H; Yasuhiro M; Kataoka K
    Bioconjug Chem; 2005; 16(1):122-30. PubMed ID: 15656583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer conjugates of acridine-type anticancer drugs with pH-controlled activation.
    Sedláček O; Hrubý M; Studenovský M; Větvička D; Svoboda J; Kaňková D; Kovář J; Ulbrich K
    Bioorg Med Chem; 2012 Jul; 20(13):4056-63. PubMed ID: 22658535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
    Lukyanov AN; Torchilin VP
    Adv Drug Deliv Rev; 2004 May; 56(9):1273-89. PubMed ID: 15109769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric anticancer drugs with pH-controlled activation.
    Ulbrich K; Etrych T; Chytil P; Pechar M; Jelinkova M; Rihova B
    Int J Pharm; 2004 Jun; 277(1-2):63-72. PubMed ID: 15158969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell.
    Calderón M; Welker P; Licha K; Fichtner I; Graeser R; Haag R; Kratz F
    J Control Release; 2011 May; 151(3):295-301. PubMed ID: 21256902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Smart' delivery systems for biomolecular therapeutics.
    Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
    Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-targeting macromolecular therapeutics.
    Wang D; Miller SC; Kopecková P; Kopecek J
    Adv Drug Deliv Rev; 2005 May; 57(7):1049-76. PubMed ID: 15876403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of anticancer drugs.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the study of tumor pH-responsive polymeric micelles for cancer drug targeting delivery].
    Xu JX; Tang JB; Zhao LH; Shen YQ
    Yao Xue Xue Bao; 2009 Dec; 44(12):1328-35. PubMed ID: 21351464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs.
    Ryu BY; Sohn JS; Hess M; Choi SK; Choi JK; Jo BW
    J Biomater Sci Polym Ed; 2008; 19(3):311-24. PubMed ID: 18325233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of anticancer prodrugs for reductive activation.
    Chen Y; Hu L
    Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy for cancer using pH-responsive nanocarrier systems.
    Manchun S; Dass CR; Sriamornsak P
    Life Sci; 2012 Mar; 90(11-12):381-7. PubMed ID: 22326503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
    Du JZ; Du XJ; Mao CQ; Wang J
    J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstrating the importance of polymer-conjugate conformation in solution on its therapeutic output: Diethylstilbestrol (DES)-polyacetals as prostate cancer treatment.
    Giménez V; James C; Armiñán A; Schweins R; Paul A; Vicent MJ
    J Control Release; 2012 Apr; 159(2):290-301. PubMed ID: 22230343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
    Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
    Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from marketed and investigational prodrugs.
    Ettmayer P; Amidon GL; Clement B; Testa B
    J Med Chem; 2004 May; 47(10):2393-404. PubMed ID: 15115379
    [No Abstract]   [Full Text] [Related]  

  • 19. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.